Table of Contents
Thanks to the stimulus of new medical system reform launched by the government in 2009, the pharmaceuticals industry of China remains steady growth. In the first half of 2009, the output of China’s chemical medicine saw negative growth, and it didn’t change for the better until the latter half of 2009, and the output of main chemical drugs showed the trend of rapid growth, and peaked in December to 215,720 tons. Besides, November 2009 ...More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Robyn
+1 (805) 652 26 26
"Analytical Tool - Hematological Cancers" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in hematological cancers. It is ...
Market Opportunities for Differentiated Therapeutics Type 2 diabetes is one of the most significant global health concerns of modern times. The size of the diabetes therapeutics market has stimulated a ...
What Pharmaceutical and Biotechnology Companies Want and How to Compete for their Business The overall objective of this study was to provide contract manufacturing organizations (CMOs) a sound basis fo ...
... Treatments, pipelines, and commercial opportunities, spectra intelligence, april 2006, pages: 369 2--melanoma therapeutics - pipeline assessment and market forecasts to 2019, globaldata 3--american cancer ...
Reportlinker.com © Copyright 2013. All rights reserved.